Literature DB >> 34958390

Biology of Activating Transcription Factor 4 (ATF4) and Its Role in Skeletal Muscle Atrophy.

Scott M Ebert1,2, Blake B Rasmussen2,3, Andrew R Judge2,4, Sarah M Judge4, Lars Larsson5, Ronald C Wek6, Tracy G Anthony7, George R Marcotte1,8, Matthew J Miller1,8, Mark A Yorek8,9, Adrian Vella1,2, Elena Volpi3, Jennifer I Stern1, Matthew D Strub1, Zachary Ryan1, John J Talley2, Christopher M Adams1,2,9.   

Abstract

Activating transcription factor 4 (ATF4) is a multifunctional transcription regulatory protein in the basic leucine zipper superfamily. ATF4 can be expressed in most if not all mammalian cell types, and it can participate in a variety of cellular responses to specific environmental stresses, intracellular derangements, or growth factors. Because ATF4 is involved in a wide range of biological processes, its roles in human health and disease are not yet fully understood. Much of our current knowledge about ATF4 comes from investigations in cultured cell models, where ATF4 was originally characterized and where further investigations continue to provide new insights. ATF4 is also an increasingly prominent topic of in vivo investigations in fully differentiated mammalian cell types, where our current understanding of ATF4 is less complete. Here, we review some important high-level concepts and questions concerning the basic biology of ATF4. We then discuss current knowledge and emerging questions about the in vivo role of ATF4 in one fully differentiated cell type, mammalian skeletal muscle fibers.
© The Author(s) 2021. Published by Oxford University Press on behalf of the American Society for Nutrition.

Entities:  

Keywords:  ATF4; sarcopenia; skeletal muscle atrophy; tomatidine; ursolic acid

Mesh:

Substances:

Year:  2022        PMID: 34958390      PMCID: PMC8970988          DOI: 10.1093/jn/nxab440

Source DB:  PubMed          Journal:  J Nutr        ISSN: 0022-3166            Impact factor:   4.798


  114 in total

Review 1.  Scissors-grip model for DNA recognition by a family of leucine zipper proteins.

Authors:  C R Vinson; P B Sigler; S L McKnight
Journal:  Science       Date:  1989-11-17       Impact factor: 47.728

2.  A novel dual kinase function of the RET proto-oncogene negatively regulates activating transcription factor 4-mediated apoptosis.

Authors:  Rozita Bagheri-Yarmand; Krishna M Sinha; Anupama E Gururaj; Zamal Ahmed; Yasmeen Q Rizvi; Su-Chen Huang; John E Ladbury; Oliver Bogler; Michelle D Williams; Gilbert J Cote; Robert F Gagel
Journal:  J Biol Chem       Date:  2015-03-20       Impact factor: 5.157

3.  Discovery of GSK2656157: An Optimized PERK Inhibitor Selected for Preclinical Development.

Authors:  Jeffrey M Axten; Stuart P Romeril; Arthur Shu; Jeffrey Ralph; Jesús R Medina; Yanhong Feng; William Hoi Hong Li; Seth W Grant; Dirk A Heerding; Elisabeth Minthorn; Thomas Mencken; Nathan Gaul; Aaron Goetz; Thomas Stanley; Annie M Hassell; Robert T Gampe; Charity Atkins; Rakesh Kumar
Journal:  ACS Med Chem Lett       Date:  2013-08-12       Impact factor: 4.345

4.  Activation of MTK1/MEKK4 by GADD45 through induced N-C dissociation and dimerization-mediated trans autophosphorylation of the MTK1 kinase domain.

Authors:  Zenshi Miyake; Mutsuhiro Takekawa; Qingyuan Ge; Haruo Saito
Journal:  Mol Cell Biol       Date:  2007-01-22       Impact factor: 4.272

Review 5.  Skeletal Muscle Atrophy: Discovery of Mechanisms and Potential Therapies.

Authors:  Scott M Ebert; Asma Al-Zougbi; Sue C Bodine; Christopher M Adams
Journal:  Physiology (Bethesda)       Date:  2019-07-01

6.  Role of the transcription factor ATF4 in the anabolic actions of insulin and the anti-anabolic actions of glucocorticoids.

Authors:  Christopher M Adams
Journal:  J Biol Chem       Date:  2007-04-12       Impact factor: 5.157

7.  Autophagy is required to maintain muscle mass.

Authors:  Eva Masiero; Lisa Agatea; Cristina Mammucari; Bert Blaauw; Emanuele Loro; Masaaki Komatsu; Daniel Metzger; Carlo Reggiani; Stefano Schiaffino; Marco Sandri
Journal:  Cell Metab       Date:  2009-12       Impact factor: 27.287

8.  Gene profiling of skeletal muscle in an amyotrophic lateral sclerosis mouse model.

Authors:  Jose-Luis Gonzalez de Aguilar; Christa Niederhauser-Wiederkehr; Benoît Halter; Marc De Tapia; Franck Di Scala; Philippe Demougin; Luc Dupuis; Michael Primig; Vincent Meininger; Jean-Philippe Loeffler
Journal:  Physiol Genomics       Date:  2007-11-13       Impact factor: 3.107

9.  Insulin signaling and the general amino acid control response. Two distinct pathways to amino acid synthesis and uptake.

Authors:  Sharon E Malmberg; Christopher M Adams
Journal:  J Biol Chem       Date:  2008-05-14       Impact factor: 5.157

10.  ATF4 differentially regulates transcriptional activation of myeloid-specific genes by C/EBPepsilon and C/EBPalpha.

Authors:  Adrian F Gombart; Jeffrey Grewal; H Phillip Koeffler
Journal:  J Leukoc Biol       Date:  2007-03-08       Impact factor: 4.962

View more
  3 in total

1.  Activation of the eIF2α-ATF4 Pathway by Chronic Paracetamol Treatment Is Prevented by Dietary Supplementation with Cysteine.

Authors:  Valérie Carraro; Lydie Combaret; Cécile Coudy-Gandilhon; Laurent Parry; Julien Averous; Anne-Catherine Maurin; Céline Jousse; Guillaume Voyard; Pierre Fafournoux; Isabelle Papet; Alain Bruhat
Journal:  Int J Mol Sci       Date:  2022-06-28       Impact factor: 6.208

Review 2.  Metabolic changes in aging humans: current evidence and therapeutic strategies.

Authors:  Allyson K Palmer; Michael D Jensen
Journal:  J Clin Invest       Date:  2022-08-15       Impact factor: 19.456

3.  Activating transcription factor 4 aggravates angiotensin II-induced cell dysfunction in human vascular aortic smooth muscle cells via transcriptionally activating fibroblast growth factor 21.

Authors:  Ke Tao; Ming Li; Xuefeng Gu; Ming Wang; Tianwei Qian; Lijun Hu; Jiang Li
Journal:  Korean J Physiol Pharmacol       Date:  2022-09-01       Impact factor: 1.718

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.